Skip to main navigation Skip to search Skip to main content

Translation and initial validation of the Chinese (cantonese) version of community integration measure for use in patients with chronic stroke

    Research output: Contribution to journalArticlepeer-review

    40 Citations (Scopus)

    Abstract

    Objectives. To (1) translate and culturally adapt the English version Community Integration Measure into Chinese (Cantonese), (2) report the results of initial validation of the Chinese (Cantonese) version of CIM (CIM-C) including the content validity, internal consistency, test-retest reliability, and factor structure of CIM-C for use in stroke survivors in a Chinese community setting, and (3) investigate the level of community integration of stroke survivors living in Hong Kong. Design. Cross-sectional study. Setting. University-based rehabilitation centre. Participants. 62 (n = 62) subjects with chronic stroke. Methods. The CIM-C was produced after forward-backward translation, expert panel review, and pretesting. 25 (n = 25) of the same subjects were reassessed after a 1-week interval. Results. The items of the CIM-C demonstrated high internal consistency with a Cronbach's alpha of 0.84. The CIM-C showed good test-retest reliability with an intraclass correlation coefficient (ICC) of 0.84 (95% confidence interval, 0.64-0.93). A 3-factor structure of the CIM-C including "relationship and engagement," "sense of knowing," and "independent living," was consistent with the original theoretical model. Hong Kong stroke survivors revealed a high level of community integration as measured by the CIM-C (mean (SD): 43.48 (5.79)). Conclusions. The CIM-C is a valid and reliable measure for clinical use.

    Original languageEnglish
    Article number623836
    JournalBioMed Research International
    Volume2014
    DOIs
    Publication statusPublished - 2014

    Fingerprint

    Dive into the research topics of 'Translation and initial validation of the Chinese (cantonese) version of community integration measure for use in patients with chronic stroke'. Together they form a unique fingerprint.

    Cite this